EMA Recommends Approval of Rasonque for Metastatic Pancreatic Cancer
The European Medicines Agency's committee has recommended marketing authorisation for Rasonque (daraxonrasib), an oral treatment…
EMA’s CHMP Recommends Six New Medicines and Updates Therapeutic Indications in October 2026 Meeting
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval for…